Albiglutide
Albiglutide
Albiglutide (pronounced al-bi-gloo-tide) is a glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist) medication used for the treatment of Type 2 diabetes. It is marketed under the brand name Eperzan in the European Union and Tanzeum in the United States.
Etymology
The name "Albiglutide" is derived from the Latin words "albus" meaning white and "glutis" meaning buttock, referring to the injection site of the medication.
Usage
Albiglutide is used in conjunction with diet and exercise to improve glycemic control in adults with Type 2 diabetes. It is not recommended for the treatment of Type 1 diabetes or diabetic ketoacidosis.
Mechanism of Action
Albiglutide works by increasing the amount of insulin released by the pancreas in response to food intake. It also slows gastric emptying and reduces the amount of glucose produced by the liver.
Side Effects
Common side effects of Albiglutide include nausea, diarrhea, and weight loss. Serious side effects may include pancreatitis and hypersensitivity reactions.
Contraindications
Albiglutide is contraindicated in patients with a history of hypersensitivity to Albiglutide or any of its components. It is also contraindicated in patients with a history of pancreatitis.
Related Terms
- Glucagon-like peptide-1 receptor agonist
- Type 2 diabetes
- Insulin
- Pancreas
- Glycemic control
- Type 1 diabetes
- Diabetic ketoacidosis
- Pancreatitis
- Hypersensitivity
External links
- Medical encyclopedia article on Albiglutide
- Wikipedia's article - Albiglutide
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski